These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9661205)
21. A nail in the coffin for DNA sequence patents? Yamanaka M Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072 [No Abstract] [Full Text] [Related]
22. Supreme Court rules against drug patent "evergreening". Kondro W CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081 [No Abstract] [Full Text] [Related]
23. The Hatch-Waxman Act during patent prosecution and beyond. Mahn TG Food Drug Law J; 1999; 54(2):233-6. PubMed ID: 11758578 [No Abstract] [Full Text] [Related]
24. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984. Lewis RA J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987 [No Abstract] [Full Text] [Related]
25. FDA's role in administering the Hatch-Waxman Act. Malkin BJ Food Drug Law J; 1999; 54(2):211-4. PubMed ID: 11758575 [No Abstract] [Full Text] [Related]
26. Patenting drug products: anticipating Hatch-Waxman issues during the claims drafting process. Mahn TG Food Drug Law J; 1999; 54(2):245-53. PubMed ID: 11758582 [No Abstract] [Full Text] [Related]
27. Plagiarized report on patent laws shames Indian scientists. Padma TV Nat Med; 2007 Apr; 13(4):392. PubMed ID: 17415362 [No Abstract] [Full Text] [Related]
28. Data protection for " innovative drugs"--guidance now final. McMahon E; Reguly T Health Law Can; 2009 May; 29(3):44-5. PubMed ID: 19702233 [No Abstract] [Full Text] [Related]
29. Science and law. The obvious war. Samardzija MR Science; 2007 Jan; 315(5809):190-1. PubMed ID: 17218511 [No Abstract] [Full Text] [Related]
31. The biotechnology industry organization's view on Hatch-Waxman reform. Schmickel D Food Drug Law J; 1999; 54(2):241-2. PubMed ID: 11758580 [No Abstract] [Full Text] [Related]
32. Old laws stop drugs being used in valuable new ways. Berger SP Nature; 2007 Oct; 449(7165):972. PubMed ID: 17960214 [No Abstract] [Full Text] [Related]
34. Where have all the antibiotic patents gone? Katz ML; Mueller LV; Polyakov M; Weinstock SF Nat Biotechnol; 2006 Dec; 24(12):1529-31. PubMed ID: 17160057 [TBL] [Abstract][Full Text] [Related]
35. [End of the drug monopoly in Norway?]. Lunde PK Tidsskr Nor Laegeforen; 1991 Jan; 111(1):95-6. PubMed ID: 2000599 [No Abstract] [Full Text] [Related]
36. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
37. Administrative drug submissions to be excluded from the PM(NOC) regulations? Cheung RY Health Law Can; 2011 Nov; 32(2):35. PubMed ID: 22259975 [No Abstract] [Full Text] [Related]
38. Protecting the balance of Hatch-Waxman: understanding the industry's new dynamics for the 21st century. Schroeder RG; Papas P Food Drug Law J; 2001; 56(1):19-26. PubMed ID: 11942348 [No Abstract] [Full Text] [Related]